General
Fmoc-L-amino acids were purchased from Novabiochem (Melbourne, Australia) and Peptides were synthesized manually by standard solid phase methods using HBTU or HATU/DIPEA activation of Fmoc protected amino acids on Rink amide resin (substitution 0.35 mmol/g).
Manual Synthesis
All peptides were assembled on Rink Amide resin at 0.1 mmol scale. Two equivalents of Fmoc-protected amino acid, 2.0 equivalents of HBTU, and 2.0 equivalents of DIPEA were employed in each coupling. For specialty protected amino acid 5 and Fmoc-Lys(Alloc)-OH, 2 equivalents of Fmoc-protected amino acid, 2 equivalents of HATU, and 4.5 equivalents of Collidine or 2 equivalents of DIPEA were employed in each coupling. Fmoc deprotections were achieved by 2 min treatments with excess 20% piperidine in DMF. Coupling progress was monitored by ninhydrin test.
Peptide Cyclization (Solid Phase)
The allyl protecting group of compound 5 and alloc group of lysine were removed from the peptide-resin with 20% Pd(Ph 3 ) 4 (Tetrakis(triphenylphosphine)palladium) in dichloromethane (DCM) in the presence of 20 equivalents phenylsilane (2 hours).
Then the resin was washed with DMF, DCM, DMF, and DCM until the dark colour disappears. The cyclization of the resin bound peptide was performed with PyBOP (4.0 equiv) and Collidine (4.5 equiv) in DMF for 4 hours or overnight at room temperature.
Peptide Cleavage
The peptide was cleaved from the resin by treatment with a 5 mL solution containing 95% trifluoroacetic acid (TFA): 2.5% H 2 O: 2.5% triisopropylsilane (TIPS) for 1.5
hours at room temperature. TFA solutions were filtered and evaporated under N 2 . The peptides were purified by semi-preparative rp-HPLC on a 22 × 250 mm column using a linear gradient ACN/H 2 O (0% B to 40% B over 40 min).
Semi-preparative rp-HPLC purification
Semi-preparative rp-HPLC purification of the peptides was performed using a a Shimadzu where c is the concentration, S is the integral (in absolute units) number of protons, T
Percentage Helicity 2
Percentage helicity of peptides were calculated from residue-molar eliticity at 220 nm using eq
is the maximum theoretical mean residue ellipticity for a helix of n residues, [θ] ∞ is the mean residue ellipticity of an infinite helix, and x is an empirical constant that can be interpreted as the effective number of amides missing as a result of end effects, usually about 2.4-4 (we used x=2.5) and
[θ] ∞ = (-44000 + 250T) (T is temperature of the peptide solution in °C).
[θ] 0 is the mean residue ellipticity of the peptide in random coil conformation and equals to (2220 -53T) and [θ] 220 ([θ] 220 = 1/n . [θ obs ]/(10 x l x C)) is the observed residue ellipticity of peptide at 220 nm. Where θ obs = measured ellipticity in mdeg; n = number of peptide residues; C = sample concentration (mol/L); l = optical path length of the cell in cm.
NMR Spectroscopy
The samples for the NMR analyses of peptides were prepared by dissolving the 
Structure Calculations 3
The distance restraints used in calculating the structure for peptides in water were derived from ROESY spectra (recorded at 298K, 293K for 9) using mixing time of 300 ms (ROESY). ROE cross-peak volumes were classified manually as strong (upper distance constraint ≤ 2.7Å), medium (≤ 3.5Å), weak (≤ 5.0Å) and very weak (≤ 6.0Å). Standard pseudoatom distance corrections were applied for nonstereospecifically assigned protons. To address the possibility of conformational averaging, intensities were classified conservatively and only upper distance limits were included in the calculations to allow the largest possible number of conformers to fit the experimental data. Backbone dihedral angle restraints were inferred from 3 JNHCHα coupling constants in 1D spectra, φ was restrained to -65 ± 30° for 
Synthesis and analysis of 5

Synthesis
Compound 2 was prepared based on literature. 4 The NMR data was consistent with the reported data. Compound 4 was prepared as literature reported method, 5 with some modifications, the 1 H spectrum is consistent with data in literature.
Step 1. D-Glucuronic acid 1 (3.88 g, 20 mmol) was dissolved in 50 mL acetic anhydride and the mixture stirred in ice-water bath. Catalytic amount of Iodine (0.065 equiv, 330 mg) was added in portions and the red solution stirred at 0 ºC for 2 h. The ice-water bath was removed and the reaction mixture stirred for further 3 h. Acetic anhydride was removed under high vacuum. The residue was dissolved in DCM (60 mL). The solution was washed with 10% aqueous Na 2 S 2 O 3 solution (2 × 30 mL), brine and dried (MgSO 4 ). The solution was filtered and the filtrate concentrated under vacuum to dryness to give the crude mixed anhydride 2.
Step 2. The above crude was dissolved in THF (20 mL) and water (10mL). phase was dried and evaporated under vacuum to provide the crude compound 3, which was used without further purification.
Step 3. The above crude 3 (5.8 g, 16 mmol) was dissolved in DMF (40 mL), Step 4. A mixture of peracetylated allyl glucuronate 4 (4 g, 9.95 mmol) and
Fmoc-Ser-OH (6.5 g, 20 mmol) were dried by co-evaporation with anhydrous toluene (3× 5 mL 
Analytical data for linear peptides
